Literature DB >> 3519446

A novel polymorphism of human complement component C3 detected by means of a monoclonal antibody.

C Koch, N Behrendt.   

Abstract

A mouse monoclonal antibody, HAV 4-1, obtained after immunization of a BALB/c mouse with purified C3F, detected a novel genetic polymorphism of human complement component C3 in a simple immunoblotting system. The frequency of HAV 4-1-positive genes was 20.1%. Reactivity of HAV 4-1 was closely related to C3F, but certain individuals with the C3F allele did not react with HAV 4-1. Conversely, certain C3S homozygous individuals did react with HAV 4-1. The polymorphism detected by this monoclonal antibody is therefore different from the previously described polymorphism based on charge differences.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3519446     DOI: 10.1007/bf00398796

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  19 in total

1.  Hypomorphic variant of C3, arthritis, and chronic glomerulonephritis.

Authors:  R H McLean; A Weinstein; I Damjanov; N Rothfield
Journal:  J Pediatr       Date:  1978-12       Impact factor: 4.406

2.  Capacity of complement c3 phenotypes to bind on to mononuclear cells in man.

Authors:  H Arvilommi
Journal:  Nature       Date:  1974-10-25       Impact factor: 49.962

3.  Studies of the C3 polymorphism. Rlationship between C3 phenotypes and rheumatoid arthritis.

Authors:  R Brönnestam
Journal:  Hum Hered       Date:  1973       Impact factor: 0.444

4.  C3 polymorphism in a group of old arteriosclerotic patients.

Authors:  J Dissing; J Lund; H Sorensen
Journal:  Hum Hered       Date:  1972       Impact factor: 0.444

5.  The molecular basis for isozymes.

Authors:  C L Markert
Journal:  Ann N Y Acad Sci       Date:  1968-06-14       Impact factor: 5.691

6.  Allotypes of C3 in laboratory and wild mouse distinguished by alloantisera.

Authors:  S Natsuume-Sakai; K Moriwaki; S Amano; J Hayakawa; T Kaidoh; M Takahashi
Journal:  J Immunol       Date:  1979-07       Impact factor: 5.422

7.  Linkage between familial hypercholesterolemia with xanthomatosis and the C3 polymorphism confirmed.

Authors:  K Berg; A Heiberg
Journal:  Cytogenet Cell Genet       Date:  1978

Review 8.  Membrane attack by complement.

Authors:  E R Podack; J Tschopp
Journal:  Mol Immunol       Date:  1984-07       Impact factor: 4.407

Review 9.  The proteolytic activation systems of complement.

Authors:  K B Reid; R R Porter
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

10.  Linkage analysis of myotonic dystrophy and sequences on chromosome 19 using a cloned complement 3 gene probe.

Authors:  K E Davies; J Jackson; R Williamson; P S Harper; S Ball; M Sarfarazi; L Meredith; G Fey
Journal:  J Med Genet       Date:  1983-08       Impact factor: 6.318

View more
  4 in total

1.  A novel protein polymorphism of human complement C7 detected by a monoclonal antibody.

Authors:  R Würzner; M J Hobart; A Orren; K Tokunaga; R Nitze; O Götze; P J Lachmann
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Molecular analysis of C3 allotypes in patients with nephritic factor.

Authors:  J E Finn; P W Mathieson
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

Review 3.  The role of the alternative pathway of complement activation in glomerular diseases.

Authors:  Emilia Łukawska; Magdalena Polcyn-Adamczak; Zofia I Niemir
Journal:  Clin Exp Med       Date:  2018-02-15       Impact factor: 3.984

4.  Molecular basis of polymorphisms of human complement component C3.

Authors:  M Botto; K Y Fong; A K So; C Koch; M J Walport
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.